基于第二代测序的T细胞受体γ基因重排诊断检测验证:从毛细管电泳过渡到第二代测序 2021年4月21日|2021年出版物,出版物marketing2021-12-19T07:20:39+00:00April 20th, 2021|更多详细信息
Validation and interpretation of IGH and TCR clonality testing by Ion Torrent S5 NGS for diagnosis and disease monitoring in B and T cell cancersmarketing2021-02-11T19:51:54+00:00November 25th, 2020|更多详细信息
Classification of intestinal T‐cell receptor repertoires using machine learning methods can identify patients with coeliac disease regardless of dietary gluten statusmarketing2021-02-11T19:57:34+00:00November 22nd, 2020|更多详细信息
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testingmarketing2021-02-17T18:10:07+00:00November 17th, 2020|更多详细信息
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myelomamarketing2021-02-11T20:05:42+00:00October 30th, 2020|更多详细信息
Kronos Bio and Invivoscribe Partner on Companion Diagnosticmarketing2022-08-22T21:30:25+00:00August 16th, 2022|更多详细信息
Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicinewmm2022-05-11T14:41:48+00:00May 9th, 2022|更多详细信息
Roswell Park综合癌症中心授权Invvivoscribe的LymphoTrack软件即插即用管道使用 2021年9月2日|2021年新闻发布,新闻发布marketing2021-12-19T07:18:11+00:00September 2nd, 2021|更多详细信息
Invivoscribe宣布向欧盟递交关键申报资料,扩大在中国的影响力和活动 2021年7月22日|2021年新闻发布,新闻稿marketing2021-12-19T07:20:17+00:00July 22nd, 2021|更多详细信息
Next Generation Dx SummitAugust 24-26, 2021 WASHINGTON, DC IN-PERSON BOOTH #105 / SYMPOSIUM https://www.nextgenerationdx.com
GFHC CongressSeptember 22-24, 2021 IN-PERSON BOOTH NANCY, FRANCE http://gfhc.fr/portfolio/congres-nancy-2021/